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Background: New standardised parenteral nutrition (SPN) formulations were implemented in July 2011 in many
neonatal intensive care units in New South Wales following consensus group recommendations. The aim was to
evaluate the efficacy and safety profile of new consensus formulations in preterm infants born less than 32 weeks.
Methods: A before-after intervention study conducted at a tertiary neonatal intensive care unit. Data from the
post-consensus cohort (2011 to 2012) were prospectively collected and compared retrospectively with a
pre-consensus cohort of neonates (2010).
Results: Post-consensus group commenced parenteral nutrition (PN) significantly earlier (6 v 11 hours of age,
p 0.005). In comparison to the pre-consensus cohort, there was a higher protein intake from day 1 (1.34 v 0.49 g/kg,
p 0.000) to day 7 (3.55 v 2.35 g/kg, p 0.000), higher caloric intake from day 1 (30 v 26 kcal/kg, p 0.004) to day 3 (64 v
62 kcal/kg, p 0.026), and less daily fluid intake from day 3 (105.8 v 113.8 mL/kg, p 0.011) to day 7 (148.8 v 156.2 mL/kg,
p 0.025), and reduced duration of lipid therapy (253 v 475 hr, p 0.011). This group also had a significantly greater weight
gain in the first 4 weeks (285 v 220 g, p 0.003).
Conclusions: New consensus SPN solutions provided better protein intake in the first 7 days and were associated
with greater weight gain in the first 4 weeks. However, protein intake on day 1 was below the consensus goal of
2 g/kg/day.
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Parenteral nutrition (PN) is an essential component in the
management of many newborn infants, particularly pre-
mature low birth weight infants admitted to Newborn
Intensive Care Units (NICUs) [1]. In many NICUs in
Australia and New Zealand (ANZ), PN is provided by
standardised stock solutions rather than individualised so-
lutions prescribed and prepared for each infant. Standard-
ized PN (SPN) solutions have been shown to provide
improved nutrition to infants compared to individualized* Correspondence: Srinivas.bolisetty@sesiahs.health.nsw.gov.au
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unless otherwise stated.PN solutions [2]. Until recently, each NICU in ANZ used
their own standardised PN solutions. In 2010, a multidis-
ciplinary group was formed to achieve a consensus on the
formulations acceptable to the majority of the NICUs.
Literature review was undertaken for each nutrient and
recommendations were developed in a series of meetings
held between November 2010 and April 2011. Three
standard and 2 optional amino acid/dextrose formulations
and one lipid emulsion were in the consensus. The de-
tailed outcomes and recommendations of the consensus
group have been published [3].
Royal Hospital for Women (RHW) is a tertiary peri-
natal centre in New South Wales with over 4000 deliv-
eries per year. Neonatal Intensive Care Unit (NICU) atThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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medical and surgical conditions. RHW was among the
first 3 NICUs in NSW that implemented the new man-
agement protocol from July 2011.
The main objective of this study was to evaluate the
nutritional intakes and weight gain in preterm infants
born less than 32 weeks managed in our NICU using
the new consensus SPN management protocol.
We aimed to study the following: (1) determine daily
fluid, essential nutrient (protein, carbohydrate, lipids)
and energy intakes received through parenteral and en-
teral nutrition in the first week and on day 14, 21 and 28
if the infant was still in NICU; (2) identify the incidence
of electrolyte and other metabolic disturbances in the
first week; (3) examine the limiting factors in achieving
projected nutritional intake from the consensus PN solu-
tions; and (4) compare the PN and enteral nutritional in-
takes and growth patterns between two cohort groups.
We hypothesised that protein and energy intakes of in-
fants would improve with implementation of new con-
sensus SPN formulations in 2011.
Methods
This is a before-after intervention study involving 2 cohorts
of preterm infants born less than 32 weeks. The post-
consensus cohort included infants admitted to RHW NICU
between 1st August 2011 and 31st July 2012. All data from
this cohort were prospectively collected. A pre-consensus
cohort acted as control and included infants admitted be-
tween 1st January 2010 and 31st December 2010. Data from
this cohort were collected retrospectively. There was a
6 month transition period between 2 cohorts during which
the new consensus PN management protocol was prog-
ressively introduced with regular education and training
of staff with full implementation in July 2011. We ex-
cluded neonates with major congenital malformations and
chromosomal anomalies and those who were born else-
where and transferred to RHW after 24 hours of age.
Primary outcome measures were fluid, energy and major
nutrient intakes during the first week of life, days 14, 21
and 28. Secondary outcomes measures were biochemical
parameters including daily pH, PCO2, HCO3, base excess,
plasma ionized calcium, plasma sodium, chloride, urea, cre-
atinine, albumin and magnesium for the first 7 days of life.
Liver function tests, calcium, phosphate and magnesium
were done weekly in the first 4 weeks of life and then fort-
nightly to monthly until 36 weeks corrected age or dis-
charge. Weight percentiles were based on the Australian
birth weight percentiles by gestational age [4].
Statistical analyses were performed using SPSS version
20.0. Data are presented as number (%) or median (Inter-
quartile range, IQR). The clinical and demographic char-
acteristics of the infants were compared using chi-square
test with continuity correction, t-test, and Mann? WhitneyU-test where appropriate. All p values were two-sided and
the p < 0.05 was considered statistically significant.
The study was approved by the South Eastern Sydney
and Illawarra Area Health Service Human Research Ethics
Committee-Northern Sector.
PN formulations used in 2010 (pre consensus cohort)
and the new consensus PN formulations introduced in
2011 (Post consensus cohort) are reported in Additional
files 1 and 2 respectively. The major difference in the
formulations (Additional file 3) is the protein content.
Using 2010 solutions the infant received a maximum
3 g/kg/day of protein at 150 ml/kg/day, whilst in 2011
the infant received a maximum 4 g/kg/day of protein at
135 ml/kg/day. Since 2011 the water content of lipid
emulsions (15 ml/kg at 3 g/kg/day) has been included in
the total fluid intake. There were also several changes to
sodium, chloride, acetate, calcium, magnesium, trace ele-
ments and heparin in the PN formulations.
Results
Figure 1 shows the study population. Between January
1st 2010 - December 31st 2010 and August 1st 2011-July
31st 2012, a total of 190 neonates born with gestational
age <32 weeks were admitted. Three neonates with
major congenital anomalies (tracheo-esophageal fistula,
meconium ileus with cystic fibrosis and trisomy 9) and
34 neonates who were born elsewhere and transferred to
our NICU after 24 hours of age were excluded. The
remaining 153 neonates who met eligibility criteria were
included in the study and divided into pre (N = 68) and
post-consensus (N = 85) groups.
The maternal and neonatal characteristics at birth
were similar in both groups (Table 1).
Daily nutritional intakes for the first week and on days
14, 21 and 28 were measured and a summary is reported
in Table 2. Some infants were transferred to non-tertiary
care units for ongoing care and nutrient data were avail-
able only for their stay in our NICU.
Age of commencement of amino acid (AA) was signifi-
cantly earlier in the post-consensus group compared to the
pre-consensus group (6 hours v 11 hours of age, p 0.005),
but the duration of AA supplementation remained similar.
Median AA intake was significantly higher from day 1
(1.34 g/kg) to day 7 (3.55 g/kg) in the post-consensus
group and continued to be higher on days 21 and 28
though the majority of neonates were on enteral feeds by
that time. Age of commencement of lipid was similar in
both groups (29 hours v 26 hours of age) but the duration
was significantly reduced in the post-consensus group
(253 hours v 475 hr, p 0.011). Daily caloric intake was sig-
nificantly higher from day 1 to day 3 (30, 48 and 64 kcal/
kg respectively) in the post-consensus group as compared
to the pre-consensus group (26, 44, 62 kcal/kg respect-
ively). However, calorie intakes were similar between the 2
Figure 1 Study population.
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the first 2 days. From day 3 to day 7, the post-consensus
group received significantly less daily fluid intake in com-
parison to other group.
Biochemical parameters monitored during the study
period are shown in Table 3. Arterial/capillary pH remained
similar in both cohorts from day 1 to day 3. From day 4 to
day 7, infants in the post-consensus group had higher pH
(>7.3) along with significantly higher bicarbonate (26 v









Gestational age at birth,
weeks (Median ? IQR)
28.5 (3) 29 (2) 0.218
Birth weight, g (Median ? IQR) 1110 (580) 1240 (614) 0.243
BW percentile, (Median ? IQR) 47.5 (44) 45 (41) 0.868
SGA, <10th percentile 5 (7.4%) 14 (16.5) 0.089
Male gender 34 (50%) 40 (47.1%) 0.718
Antenatal steroids 58 (85.3%) 70 (82.3%) 0.352
Chorioamnionitis 11 (16.2%) 8 (9.4%) 0.207
Pre eclampsia 14 (20.6%) 22 (25.9%) 0.443
Outborn 3 (4.4%) 5 (5.9%) 0.685
SVD 18 (26.5%) 31 (36.5%) 0.188
Apgar <7 at 5 min 12 (17.6%) 11 (12.9%) 0.418
Numbers (%) are given unless indicated.This effect disappeared on days 14, 21 and 28 as pH, bi-
carbonate and base excess values remained similar between
the 2 groups. During the study period arterial/capillary
pCO2 remained similar in both groups.
Urea was significantly higher from day 1 (5.6 v 4.1 mmol/L,
p 0.012) and increased slowly up to day 7 (8.8 v 4.8 mmol/L,
p 0.000) in the post-consensus group. None of the neonates
from either study group had cholestasis.
Clinical outcomes are shown in Table 4. The post-
consensus PN group had significantly less days of respi-
ratory support (20.2 days) compared to the pre- consensus
PN group (20.2 days v 34 days, p 0.009). Rates of chronic
lung disease trended lower in the post-consensus group but
did not reach statistical significance (p 0.056). Discharge
weight percentiles trended higher in the post-consensus
group but did not reach statistical significance. Other
neonatal mordities were similar between the 2 groups.Discussion
The detailed consensus agreement of the neonatal PN
consensus group was published previously. Main points
of agreement were to (1) provide a protein intake of
2 g/kg/day on day 1 and to increase the maximum to
4 g/kg/day by day 5; (2) restricted fluid regimen with
60 ml/kg/day on day 1 to a maximum parenteral fluid
intake of 150 ml/kg/day; (3) inclusion of lipid emulsion
in the total parenteral fluid intake; and (4) partial re-
placement of chloride with acetate to reduce hyper-
chloremic metabolic acidosis.









AA 11 (25) 6 (10) 0.005
Lipids 19 (29) 24.5 (26) 0.394
Duration of TPN, hr
AA 483 (357) 301.5 (205) 0.128
Lipids 475 (357) 253.5 (180) 0.011
Age at 1 g/kg/day of
lipid, hr
19 (29) 26 (30) 0.294
Age at 2 g/kg/day of
lipid, hr
46 (22) 56.50 (28) 0.004
Age at 3 g/kg/day of
lipid, hr
73 (24) 82 (40) 0.010
Day 1
Protein, g/kg 0.49 (0.83) 1.34 (1.16) 0.000
Lipid, g/kg 0.17 (0.73) 0.09 (0.6) 0.295
Calories, kcal/kg 26.49 (6.86) 30.23 (11.04) 0.004
Total fluid (ml/kg) 63.15 (14) 62.24 (16.3) 0.572
AA/Dex (ml/kg) 8.59 (39.6) 38.76 (37.92)
Day 3
Protein, g/kg 1.73 (0.45) 2.86 (0.81) 0.000
Lipid, g/kg 1.98 (0.77) 1.80 (1.15) 0.190
Calories, kcal/kg 62.20 (7.41) 64.24 (14.61) 0.026
Total fluid (ml/kg) 113.76 (19.07) 105.88 (15.07) 0.011
AA/Dex (ml/kg) 84.42 (25) 84.40 (27.07)
Day 7
Protein, g/kg 2.35 (0.78) 3.55 (0.89) 0.000
Lipid, g/kg 3.24 (1.77) 3.44 (1.55) 0.784
Calories, kcal/kg 90.2 (26.56) 95.92 (14.28) 0.134
Total fluid (ml/kg) 156.20 (27.3) 148.88 (11.6) 0.025
AA/Dex (ml/kg) 91.26 (47.07) 88.60 (70.19)
Day 14
Protein, g/kg 2.58 (0.73) 3.58 (1.67) 0.066
Lipid, g/kg 5.1 (2.8) 5.98 (2.81) 0.121
Calories, kcal/kg 101.94 (23.36) 106.3 (36.97) 0.515
Total fluid (ml/kg) 155.74 (18.5) 155.34 (24.9) 0.580
Day 21
Protein, g/kg 2.87 (1.36) 3.70 (0.59) 0.005
Lipid, g/kg 6.06 (2.48) 6.45 (1.57) 0.127
Calories, kcal/kg 113.65 (31.88) 122.66 (33.23) 0.139
Total fluid (ml/kg) 155.39 (18) 161.19 (21.7) 0.34
Table 2 Nutritional intakes of the study population
(Continued)
Day 28
Protein, g/kg 3.42 (1.48) 3.69 (0.46) 0.002
Lipid, g/kg 6.16 (1.47) 6.62 (0.82) 0.010
Calories, kcal/kg 117 (27.02) 126.8 (22.66) 0.010
Total fluid (ml/kg) 155.93 (17.8) 162.47 (17.5) 0.034
All numbers are Median ? IQR.
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significantly higher parenteral protein and lower fluid in-
take in the first few days in comparison to the pre-
consensus group. Higher protein intakes coincided with
higher blood urea nitrogen levels in the post-consensus
group. Consensus PN solutions were designed to provide
2 g/kg/day of amino acid on day 1 and to increase to 4 g/







pH 7.30 (0.3) 7.30 (0.1) 0.112
PCO2 43 (18.8) 48 (15) 0.244
HCO3 22.65 (4.8) 23.7 (4) 0.073
Base excess −2.3 (4.3) −1.55 (4.3) 0.091
Sodium 138 (4) 139 (3) 0.136
Chloride 108.5 (5) 107 (6) 0.269
Urea 4.15 (2.3) 5.60 (2.4) 0.012
Creatinine 66.5 (24) 68 (19) 0.940
Day 3
pH 7.23 (0.3) 7.31 (0.1) 0.09
PCO2 40 (11.8) 42 (12) 0.998
HCO3 19.8 (3.4) 20.65 (4.1) 0.564
Base excess −4.8 (4.4) −4.65 (5.2) 0.684
Sodium 141.5 (4) 144 (6) 0.000
Chloride 112 (5) 111 (6) 0.144
Urea 6.15 (3.5) 8.20 (5.0) 0.000
Creatinine 78.5 (27) 67 (26) 0.006
Day 7
pH 7.29 (0.12) 7.37 (0.07) 0.000
PCO2 45.65 (11) 46.5 (9.8) 0.483
HCO3 22.5 (3.48) 26.15 (4.65) 0.000
Base excess −2.6 (3.73) 1.75 (4.13) 0.000
Sodium 136 (4) 139 (5) 0.001
Chloride 106.5 (6) 103 (4) 0.000
Urea 4.4 (3.3) 7.7 (3.9) 0.000
Creatinine 61 (33) 57 (20) 0.378
All values are mmol/L except pH.
Table 4 Neonatal outcomes
Pre-consensus Post-consensus PN Group P Value
PN Group (N = 68) (N = 85)
Hypotension needing inotropic support 7 (10.3) 6 (7.1) (OR 0.66, 95% CI 0.21, 2.07) 0.476
Days of respiratory support (Mean ? SD) 34 (?35.90) 20.2 (?25.72) 0.009
CLD 19 (27.9) 13 (15.3) (OR 0.46, 95% CI 0.21, 1.02) 0.056
Sepsis (Early and late onset) 14 (20.6) 10 (11.7) (OR 0.51, 95% CI 0.21, 1.24) 0.315
PDA needing treatment 24 (35) 20 (23.5) (OR 0.56, 95% CI 0.27, 1.14) 0.277
NEC > stage II 6 (8.8) 3 (3.5) (OR 0.37, 95% CI 0.09, 1.57) 0.167
ROP stage III and above 4 (5.9) 3 (3.6) (OR 0.58, 95% CI 0.12, 2.70) 0.510
IVH > Grade II 7 (10.3) 7 (8.3) (OR 0.78, 95% CI 0.26, 2.34) 0.678
PMA at discharge/Transfer, wk 36.7 (?5.01) 34.8 (?3.76) 0.013
Discharge weight, g (Mean ? SD) 2141 (?796.24) 1978 (?672.74) 0.183
Discharge weight percentile (Mean ? SD) 12.6 (?15.28) 17.2 (?16.9) 0.016
Weight gain by 4 weeks age, g (Mean ? SD) 218.8 (?155.47) 264.9 (?234.15) 0.003
Mortality 5 (7.35) 3 (3.52) (OR 0.46, 95% CI 0.10, 2.00) 0.291
Numbers (%) are given unless indicated. PMA, Postmenstrual age in weeks.
Bolisetty et al. BMC Pediatrics 2014, 14:309 Page 5 of 7
http://www.biomedcentral.com/1471-2431/14/309protein intake achieved in our cohort was 1.34 g/kg/day
which was below the goal of 2 g/kg/day on day 1. Although
neonates received 62 ml/kg/day of intravenous fluids on
day 1, the amount of amino acid/dextrose solution received
was only 39 ml/kg/day. A PN solution with 5% amino acids
would be required to provide 2 g/kg/day of protein at
40 ml/kg/day. Our consensus starter solution contained
3.3% amino acids, the maximum amount of amino acids
for which physicochemical stability was guaranteed by the
pharmaceutical company during the consensus meetings.
There is insufficient evidence to determine optimal tim-
ing of introduction of lipid. Systematic review of trials of
early introduction of lipid found no significant difference
in outcomes comparing early versus late introduction [9].
Consensus was that lipids can be started with the intro-
duction of AAD solutions [10]. There was no consensus
among the consensus group on time of initiation of lipid
in infants <800 g. ESPGHAN 2005 recommends lipid
emulsion should be started no later than on the third day
in any neonate who is not sufficiently enterally fed [1]. In
this study lipid emulsion infusion was started on day 1
along with AAD solutions in all gestation age groups. Dur-
ing the pre-consensus period, triglyceride levels were not
monitored and lipid was increased by 1 g/kg each day to
maximum of 3 g/kg/day. In the post-consensus group tri-
glyceride levels were monitored before increasing the lipid
dose. Plasma triglycerides were measured before each in-
crease to 3 g/kg/day and then 48 hr later and then weekly
thereafter as long as the infant was on lipid emulsions. If
triglyceride levels were >2.8 mmol/L, lipid emulsions were
reduced by 1 g/kg/day but continued at least at 0.5 g/kg/
day to prevent essential fatty acid deficiency [1]. Lipid in-
takes were not significantly different between the 2 groups.
Rate of increase in lipid emulsion was significantly slowerin the post-consensus group. In the post-consensus group,
lipid infusion duration was significantly less (10.5 v
19.7 days). This corresponds with our new guidelines of
ceasing lipid emulsions once the enteral milk volume
reaches 100 ml/kg/day which provides an enteral lipid in-
take of 3.5 g/kg/day.
There were no major electrolyte disturbances (hypona-
tremia, hypernatremia, hyperkalemia or hypokalemia) in
either study group. Though the median duration of PN
solutions was 20.1 days (pre-consensus) and 12.5 days
(post-consensus), none of the infants developed choles-
tasis. The reasons could be multifactorial. Our PN solu-
tions do not contain copper and manganese trace
elements which may be associated with cholestatsis [1].
None of the study infants were diagnosed with metabolic
bone disease and calcium, phosphate and alkaline phos-
phate levels were within normal limits.
The post-consensus group had a significantly greater
weight gain in the first 4 weeks compared to the
pre-consesus group. However, there was no significant
difference in weight in the post-consensus group at trans-
fer/discharge likely to reflect subsequent enteral intakes
and which is consistent with the study by Clarke et al. [6].
There was a trend towards higher discharge weight percen-
tiles in the later cohort. Duration of respiratory support
was signficantly lower in the post-consensus group
although the difference in incidence of chronic lung disease
did not reach statistical significance. It is possible that the
reduced duration of respiratory support in the post-
consensus group could be related to the restricted fluid
intake and/or monitoring for lipid intolerance and also the
simultaneous introduction of a ? Golden-hour? protocol
targeting the immediate management of the very preterm
infant at birth to reduce chronic lung disease.
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lem in very low birth weight infants [11]. In our NICU, we
have been using parenteral nutrition solutions that par-
tially replace chloride with acetate for some years. New
consensus SPN formulations contain more acetate in com-
parison to pre-consensus solutions. The post-consensus
group had a higher pH, higher bicarbonate and normal
chloride levels between day 4 and 7. These results are con-
sistent with the acetate supplementation study in neonates
[11]. One of the side effects of acetate supplementation is
a higher PCO2. However, PCO2 levels were similar be-
tween the 2 groups in our study.
The purpose of providing parenteral and enteral nutri-
tion in preterm infants is to not only achieve the
intrauterine-like growth rates but also improve the mortal-
ity, morbidities and long term neurodevelopmental out-
comes. Early ? aggressive? parenteral nutrition is now the
recommended practice for very low birthweight infants
[1,12,13]. The current practice in many NICUs in Australia
is to use standard pre-mixed formulations. Our group de-
veloped consensus guidelines based on both the evidence
and the availability, compatibility and the ease of imple-
mentation of the formulations across the region in a safe
and effective way. Our philosophy was that the provision
of parenteral nutrition cannot be seen in isolation but in
the context of the other interventions such as the amount
of fluids given to these infants. However our formulations
were designed in such a way that infants receive protein,
lipid and energy intakes of 2 g/kg/day, 1 g/kg/day and
40 kcal/kg/day (Starter PN, Annexure 2) on day 1 of life.
In an effort to do this, our starter PN formulation contains
33 g/L of amino acids (Primene 10%) and 100 g/L of glu-
cose. This formulation is lot more concentrated than the
formulations used in some of the recent observational
studies published [16]. Herrmann and collegues demon-
strated a better postnatal growth with over 50% of infants
<30 weeks gestation remained above the 10th percentile of
intrauterine growth by providing early amino acids and en-
ergy intakes of at least 50 kcal/kg/day after the first
24 hours of life in 2003? 2007 cohort of 84 infants [14].
They increased the calories to 50? 70 kcal/kg/day begin-
ning 1 hour after birth in a subsequent 2009? 2010 cohort
involving 54 infants [15]. There was a significant increase
in the amount of fluids in the first 2 days of life compared
to 2003? 2007 cohort. While weight changes were similar
in the first few days between the 2 cohorts, there was no
improvement in 10th percentile growth at 36 weeks post-
menstrual age compared to 2003? 2007 cohort. There was
also a significant increase in the incidence of medical
treatment for PDA (58% v 25%), insulin for hypergly-
caemia (26% v 12%) and conjugated bilirubin >34 μmol/
L (36% v 20%). There was also a trend toward increased
incidence of NEC (8% v 1%, p 0.08). While the lack of
weight improvement at 36 weeks can be explained bychanges in enteral nutrition practice, some of the morbid-
ities may be explained by increased fluid intake [16]. Sen-
terre and colleagues from Belgium studied 102 infants
<1250 g at birth [17]. They provided mean intakes of
38 kcal/kg/day of energy and 2.4 g/kg/day of protein on
day 1 followed by mean intakes of 80 kcal/kg/day and
3.2 g/kg/day of protein in the first week. On average from
birth to discharge, 122 kcal/kg/day and 3.7 g/kg/day of pro-
tein were administered. They limited the postnatal weight
loss to the first 3 days of life, and birthweight was regained
after 7 days. Their nutrition and fluid protocol in the first
few days of life was somewhat similar to ours. However,
the strength in Senterre? s policy was not only to optimize
PN but also enteral nutrition by ensuring optimal enteral
protein intake. It is also interesting to note their policy of
discontinuing PN if enteral feeds are well tolerated once
120 mL/kg/day have been achieved and tolerated. We in-
troduced a similar policy in our consensus. This explains
the reason why the duration of PN in the post-consensus
cohort was less than the pre-consesus cohort.
We acknowledge the limitations in this study. Infants
did not receive the intended protein and energy intakes in
the first few days life. On the first day of life, aminoacid/
dextrose solution was commenced around 6 hours of life,
which was earlier than the pre-consensus group but not
from birth. The 2011? 2012 post-consensus group for this
study was immediately after the introduction of the con-
sensus guidelines. There was a 6-month transition period
(January 2011-June 2011) during which staff was given
education, training and understaning on the importance
of early nutrition and the need for change in policy in the
NICU. There were 2 incidents in our NICU during this
transition phase with lipaemic blood and very high plasma
triglycerides. This resulted in a conservative approach to
the commencement of lipids and strict monitoring of
lipids. There was also a concern in the NICU that the inci-
dence of chronic lung disease was high and there was a
quality improvement project around the same time moni-
toring the fluid intake to reduce the excess fluid intake. All
these factors might have impacted on the nutrient intakes
received by the infants during the study period. After the
completion of the enrolment for this study in July 2012, we
tightened the policy and aimed to commence the PN solu-
tions includng the lipids within 2 hours of life. We hope to
analyse the outcomes for this group soon. Other limitation
in our study was the lack of complete enteral and paren-
teral intake data from birth to discharge to determine any
improvements or variation between the cohorts.
Conclusion
In summary, consensus PN solutions provided higher pro-
tein intake in the first few days of life and were associated
with higher weight gain in the first 4 weeks despite re-
stricted fluid intake in comparison to the pre-consensus
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further improved by increasing the amino acid content in
the formulation provided physico-chemical stability of
such formulations is assured.
Additional files
Additional file 1: Standardised Amino acid-Dextrose Formulations
from January 2010 to June 2011 (Pre-consensus cohort). The table
describes the composition of standardised PN formulations in the
pre-consensus cohort.
Additional file 2: Standardised Amino acid-Dextrose formulations
from July 2011 (post-consensus cohort). The table describes the
composition of standardised PN formulations in the post-consensus cohort.
Additional file 3: Major differences in PN practice between
pre-consensus and post-consensus cohorts. This table summarises the
major improvements in the post-consensus cohort in comparison to
pre-consensus cohort.
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